Seamless Assembly of Recombinant Adenoviral Genomes from High-copy Plasmids

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Jun 28

PMID 29949649

Citations 12

Authors

Jessica J Miciak

Jason Hirshberg

Fred Bunz

Affiliations

Soon will be listed here.

Abstract

The adenoviruses are essential tools for basic research and therapeutic development. Robust methods for the generation of mutant and recombinant viruses are crucial for these diverse applications. Here we describe a simple plasmid-based method that permits highly efficient modification of the adenoviral genome and rapid production of high-titer virus stocks. The 36-kilobase genome of adenovirus serotype 5 was divided into seven tractable blocks that could be individually modified in a single step and reassembled in vitro. Because the system is composed of compact modules, modifications at different loci can be readily recombined. Viral assemblies were delivered to packaging cells by electroporation, a strategy that consistently resulted in the de novo production of 108 infectious units in 3-5 days. In principle, a similar strategy could be applied to any other adenovirus serotype or to other double-strand DNA viruses.

Citing Articles

ADEVO: Proof-of-concept of adenovirus-directed EVOlution by random peptide display on the fiber knob.

Sallard E, Fischer J, Schroeer K, Dawson L, Beaude N, Affes A Mol Ther Oncol. 2024; 32(4):200867.

PMID: 39346764 PMC: 11439537. DOI: 10.1016/j.omton.2024.200867.

Expanding the adenovirus toolbox: reporter viruses for studying the dynamics of human adenovirus replication.

King C, Dodge M, MacNeil K, Tessier T, Mymryk J, Mehle A J Virol. 2024; 98(5):e0020724.

PMID: 38639487 PMC: 11092356. DOI: 10.1128/jvi.00207-24.

Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries.

Fischer J, Fedotova A, Jaki L, Sallard E, Erhardt A, Fuchs J Mol Ther Methods Clin Dev. 2024; 32(2):101241.

PMID: 38585687 PMC: 10995876. DOI: 10.1016/j.omtm.2024.101241.

Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection.

King C, Liu Y, Amato K, Schaack G, Mickelson C, Sanders A Cell Host Microbe. 2023; 31(9):1552-1567.e8.

PMID: 37652009 PMC: 10528757. DOI: 10.1016/j.chom.2023.08.001.

Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications.

Wen K, Resch M, Mazboudi R, Mulhall Maasz H, Galarza J Front Med Technol. 2023; 5:1095198.

PMID: 36776626 PMC: 9909595. DOI: 10.3389/fmedt.2023.1095198.

References

Yu D, Jin C, Ramachandran M, Xu J, Nilsson B, Korsgren O . Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures. PLoS One. 2013; 8(1):e54952. PMC: 3555985. DOI: 10.1371/journal.pone.0054952. View

Crouzet J, Naudin L, Orsini C, Vigne E, Ferrero L, Le Roux A . Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc Natl Acad Sci U S A. 1997; 94(4):1414-9. PMC: 19805. DOI: 10.1073/pnas.94.4.1414. View

Muck-Hausl M, Solanki M, Zhang W, Ruzsics Z, Ehrhardt A . Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses. Nucleic Acids Res. 2015; 43(8):e50. PMC: 4417142. DOI: 10.1093/nar/gkv031. View

Niemann J, Kuhnel F . Oncolytic viruses: adenoviruses. Virus Genes. 2017; 53(5):700-706. DOI: 10.1007/s11262-017-1488-1. View

Yuan M, Webb E, Lemoine N, Wang Y . CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses. Viruses. 2016; 8(3):72. PMC: 4810262. DOI: 10.3390/v8030072. View

Tang X, Yang Y, Xia X, Zhang C, Yang X, Song Y . Recombinant Adenoviruses Displaying Matrix 2 Ectodomain Epitopes on Their Fiber Proteins as Universal Influenza Vaccines. J Virol. 2017; 91(7). PMC: 5355597. DOI: 10.1128/JVI.02462-16. View

Yu D, Jin C, Leja J, Majdalani N, Nilsson B, Eriksson F . Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors. J Virol. 2011; 85(24):13114-23. PMC: 3233137. DOI: 10.1128/JVI.05759-11. View

Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D . Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 2001; 15(23):3104-17. PMC: 312842. DOI: 10.1101/gad.926401. View

Uusi-Kerttula H, Legut M, Davies J, Jones R, Hudson E, Hanna L . Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies. Hum Gene Ther. 2015; 26(5):320-9. PMC: 4442602. DOI: 10.1089/hum.2015.015. View

10.

McSharry B, Burgert H, Owen D, Stanton R, Prodhomme V, Sester M . Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J Virol. 2008; 82(9):4585-94. PMC: 2293069. DOI: 10.1128/JVI.02251-07. View

11.

Jager L, Hausl M, Rauschhuber C, Wolf N, Kay M, Ehrhardt A . A rapid protocol for construction and production of high-capacity adenoviral vectors. Nat Protoc. 2009; 4(4):547-64. DOI: 10.1038/nprot.2009.4. View

12.

Bett A, Haddara W, Prevec L, Graham F . An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A. 1994; 91(19):8802-6. PMC: 44694. DOI: 10.1073/pnas.91.19.8802. View

13.

Palmer D, Ng P . Improved system for helper-dependent adenoviral vector production. Mol Ther. 2003; 8(5):846-52. DOI: 10.1016/j.ymthe.2003.08.014. View

14.

Stanton R, McSharry B, Armstrong M, Tomasec P, Wilkinson G . Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function. Biotechniques. 2009; 45(6):659-62, 664-8. DOI: 10.2144/000112993. View

15.

Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M . Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol. 1996; 70(7):4805-10. PMC: 190422. DOI: 10.1128/JVI.70.7.4805-4810.1996. View

16.

He T, Zhou S, DA COSTA L, Yu J, Kinzler K, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998; 95(5):2509-14. PMC: 19394. DOI: 10.1073/pnas.95.5.2509. View

17.

Deryckere F, Burgert H . Rapid method for preparing adenovirus DNA. Biotechniques. 1997; 22(5):868-70. DOI: 10.2144/97225bm18. View

18.

Berk A . Discovery of RNA splicing and genes in pieces. Proc Natl Acad Sci U S A. 2016; 113(4):801-5. PMC: 4743779. DOI: 10.1073/pnas.1525084113. View

19.

Crystal R . Adenovirus: the first effective in vivo gene delivery vector. Hum Gene Ther. 2014; 25(1):3-11. PMC: 3900005. DOI: 10.1089/hum.2013.2527. View

20.

Gibson D, Young L, Chuang R, Venter J, Hutchison 3rd C, Smith H . Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009; 6(5):343-5. DOI: 10.1038/nmeth.1318. View